View in EDS

Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.

Saved in:
Bibliographic Details
Title: Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.
Authors: Taube JM; Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University SOM, Baltimore, Maryland, USA jtaube1@jhmi.edu.; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA., Sunshine JC; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA., Angelo M; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA., Akturk G; Merck & Co, Rahway, New Jersey, USA., Eminizer M; Johns Hopkins University, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA., Engle LL; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA., Ferreira CS; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany., Gnjatic S; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA., Green B; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA., Greenbaum S; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA., Greenwald NF; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA., Hedvat CV; Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hollmann TJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Jiménez-Sánchez D; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA., Korski K; Department of Personalized Healthcare, Data, Analytics and Imaging Group, F Hoffmann-La Roche AG, Basel, Switzerland., Lako A; Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Parra ER; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rebelatto MC; AstraZeneca, Gaithersburg, Maryland, USA., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Rodig SJ; Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Rodriguez-Canales J; Daiichi Dankyo, Basking Ridge, New Jersey, USA., Roskes JS; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA., Schalper KA; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Schenck E; AstraZeneca, Gaithersburg, Maryland, USA., Steele KE; SR Pathology LLC, Gaithersburg, Maryland, USA., Surace MJ; AstraZeneca, Gaithersburg, Maryland, USA., Szalay AS; Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA., Tetzlaff MT; Departments of Pathology and Dermatology, University of California San Francisco, San Francisco, California, USA., Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yearley JH; Merck & Co, Rahway, New Jersey, USA., Bifulco CB; Providence Portland Medical Center, Portland, Oregon, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jan 08; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 08.
Publication Type: Journal Article; Practice Guideline
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39779210
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Taube+JM%22">Taube JM</searchLink>; Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University SOM, Baltimore, Maryland, USA jtaube1@jhmi.edu.; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sunshine+JC%22">Sunshine JC</searchLink>; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Angelo+M%22">Angelo M</searchLink>; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Akturk+G%22">Akturk G</searchLink>; Merck & Co, Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Eminizer+M%22">Eminizer M</searchLink>; Johns Hopkins University, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Engle+LL%22">Engle LL</searchLink>; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ferreira+CS%22">Ferreira CS</searchLink>; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Green+B%22">Green B</searchLink>; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Greenbaum+S%22">Greenbaum S</searchLink>; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Greenwald+NF%22">Greenwald NF</searchLink>; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Hedvat+CV%22">Hedvat CV</searchLink>; Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hollmann+TJ%22">Hollmann TJ</searchLink>; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Jiménez-Sánchez+D%22">Jiménez-Sánchez D</searchLink>; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Korski+K%22">Korski K</searchLink>; Department of Personalized Healthcare, Data, Analytics and Imaging Group, F Hoffmann-La Roche AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lako+A%22">Lako A</searchLink>; Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Parra+ER%22">Parra ER</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Rebelatto+MC%22">Rebelatto MC</searchLink>; AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rimm+DL%22">Rimm DL</searchLink>; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Rodig+SJ%22">Rodig SJ</searchLink>; Dana Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Canales+J%22">Rodriguez-Canales J</searchLink>; Daiichi Dankyo, Basking Ridge, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Roskes+JS%22">Roskes JS</searchLink>; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Schalper+KA%22">Schalper KA</searchLink>; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Schenck+E%22">Schenck E</searchLink>; AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Steele+KE%22">Steele KE</searchLink>; SR Pathology LLC, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Surace+MJ%22">Surace MJ</searchLink>; AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Szalay+AS%22">Szalay AS</searchLink>; Mark Foundation Center for Advanced Genomics and Imaging, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Bloomberg~Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, Maryland, USA.; Department of Astronomy and Physics, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Tetzlaff+MT%22">Tetzlaff MT</searchLink>; Departments of Pathology and Dermatology, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Yearley+JH%22">Yearley JH</searchLink>; Merck & Co, Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bifulco+CB%22">Bifulco CB</searchLink>; Providence Portland Medical Center, Portland, Oregon, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Jan 08; Vol. 13 (1). <i>Date of Electronic Publication: </i>2025 Jan 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Practice Guideline
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39779210
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-008875
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Taube JM
      – PersonEntity:
          Name:
            NameFull: Sunshine JC
      – PersonEntity:
          Name:
            NameFull: Angelo M
      – PersonEntity:
          Name:
            NameFull: Akturk G
      – PersonEntity:
          Name:
            NameFull: Eminizer M
      – PersonEntity:
          Name:
            NameFull: Engle LL
      – PersonEntity:
          Name:
            NameFull: Ferreira CS
      – PersonEntity:
          Name:
            NameFull: Gnjatic S
      – PersonEntity:
          Name:
            NameFull: Green B
      – PersonEntity:
          Name:
            NameFull: Greenbaum S
      – PersonEntity:
          Name:
            NameFull: Greenwald NF
      – PersonEntity:
          Name:
            NameFull: Hedvat CV
      – PersonEntity:
          Name:
            NameFull: Hollmann TJ
      – PersonEntity:
          Name:
            NameFull: Jiménez-Sánchez D
      – PersonEntity:
          Name:
            NameFull: Korski K
      – PersonEntity:
          Name:
            NameFull: Lako A
      – PersonEntity:
          Name:
            NameFull: Parra ER
      – PersonEntity:
          Name:
            NameFull: Rebelatto MC
      – PersonEntity:
          Name:
            NameFull: Rimm DL
      – PersonEntity:
          Name:
            NameFull: Rodig SJ
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Canales J
      – PersonEntity:
          Name:
            NameFull: Roskes JS
      – PersonEntity:
          Name:
            NameFull: Schalper KA
      – PersonEntity:
          Name:
            NameFull: Schenck E
      – PersonEntity:
          Name:
            NameFull: Steele KE
      – PersonEntity:
          Name:
            NameFull: Surace MJ
      – PersonEntity:
          Name:
            NameFull: Szalay AS
      – PersonEntity:
          Name:
            NameFull: Tetzlaff MT
      – PersonEntity:
          Name:
            NameFull: Wistuba II
      – PersonEntity:
          Name:
            NameFull: Yearley JH
      – PersonEntity:
          Name:
            NameFull: Bifulco CB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 01
              Text: 2025 Jan 08
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1